Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial
Journal article published in 2017 by
S. B. Sirima 
,
C. Durier,
L. Kara,
S. Houard,
A. Gansane,
P. Loulergue,
M. Bahuaud,
N. Benhamouda,
I. Nebié,
B. Faber,
E. Remarque,
O. Launay,
E. Ouedraogo,
G. Sanou,
S. Gueguen
and other authors.
,
C. Durier,
L. Kara,
S. Houard,
A. Gansane,
P. Loulergue,
M. Bahuaud,
N. Benhamouda,
I. Nebié,
B. Faber,
E. Remarque,
O. Launay,
E. Ouedraogo,
G. Sanou,
S. Gueguen
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 